Healthcare provider profile · identity verified

Hayden Head, MD

Family Practice · LINDALE, TX · NPI 1568874824

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Levothyroxine Sodium	Levothyroxine Sodium	490	133
Rosuvastatin Calcium	Rosuvastatin Calcium	376	113
Atorvastatin Calcium	Atorvastatin Calcium	373	109
Amlodipine Besylate	Amlodipine Besylate	371	109
Losartan Potassium	Losartan Potassium	306	98
Gabapentin	Gabapentin	263	86
Omeprazole	Omeprazole	263	90
Pantoprazole Sodium	Pantoprazole Sodium	223	71
Duloxetine Hcl	Duloxetine Hcl	192	44
Albuterol Sulfate Hfa	Albuterol Sulfate	191	70
Trazodone Hcl	Trazodone Hcl	190	64
Lisinopril	Lisinopril	189	57
Montelukast Sodium	Montelukast Sodium	178	66
Fluticasone Propionate	Fluticasone Propionate	154	61
Metoprolol Succinate	Metoprolol Succinate	153	48
Pravastatin Sodium	Pravastatin Sodium	147	38
Simvastatin	Simvastatin	145	38
Hydrochlorothiazide	Hydrochlorothiazide	132	44
Metformin Hcl Er	Metformin Hcl	129	44
Tramadol Hcl	Tramadol Hcl	121	26
Furosemide	Furosemide	120	43
Alprazolam	Alprazolam	117	17
Acetaminophen-Codeine	Acetaminophen With Codeine	114	34
Allopurinol	Allopurinol	114	35
Famotidine	Famotidine	114	56
Tamsulosin Hcl	Tamsulosin Hcl	113	33
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	106	27
Tizanidine Hcl	Tizanidine Hcl	102	33
Sertraline Hcl	Sertraline Hcl	101	33
Meloxicam	Meloxicam	99	31
Metoprolol Tartrate	Metoprolol Tartrate	96	30
Prednisone	Prednisone	96	70
Carvedilol	Carvedilol	95	28
Buspirone Hcl	Buspirone Hcl	94	30
Citalopram Hbr	Citalopram Hydrobromide	87	29
Metformin Hcl	Metformin Hcl	87	31
Potassium Chloride	Potassium Chloride	86	27
Cephalexin	Cephalexin	85	60
Glimepiride	Glimepiride	83	31
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	82	22
Eliquis	Apixaban	80	18
Alendronate Sodium	Alendronate Sodium	78	28
Zolpidem Tartrate	Zolpidem Tartrate	78	25
Bupropion Hcl Sr	Bupropion Hcl	77	24
Amitriptyline Hcl	Amitriptyline Hcl	73	25
Bupropion Xl	Bupropion Hcl	73	21
Escitalopram Oxalate	Escitalopram Oxalate	72	25
Estradiol	Estradiol	68	25
Lorazepam	Lorazepam	66	11
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	65	22
Ozempic	Semaglutide	65	19
Mounjaro	Tirzepatide	63	13
Spironolactone	Spironolactone	63	20
Oxybutynin Chloride Er	Oxybutynin Chloride	62	19
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	62	13
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	60	16
Synthroid	Levothyroxine Sodium	59	17
Venlafaxine Hcl Er	Venlafaxine Hcl	59	17
Esomeprazole Magnesium	Esomeprazole Magnesium	58	23
Donepezil Hcl	Donepezil Hcl	57	19
Doxepin Hcl	Doxepin Hcl	56	25
Ropinirole Hcl	Ropinirole Hcl	56	14
Doxycycline Hyclate	Doxycycline Hyclate	55	49
Ondansetron Odt	Ondansetron	53	24
Trulicity	Dulaglutide	53	13
Clonazepam	Clonazepam	47	suppressed
Memantine Hcl	Memantine Hcl	46	19
Clopidogrel	Clopidogrel Bisulfate	44	15
Fluoxetine Hcl	Fluoxetine Hcl	44	15
Finasteride	Finasteride	43	suppressed
Naproxen	Naproxen	43	21
Terazosin Hcl	Terazosin Hcl	43	suppressed
Topiramate	Topiramate	41	14
Quetiapine Fumarate	Quetiapine Fumarate	40	suppressed
Ipratropium Bromide	Ipratropium Bromide	37	21
Xarelto	Rivaroxaban	37	12
Diclofenac Sodium	Diclofenac Sodium	36	12
Ezetimibe	Ezetimibe	36	12
Pregabalin	Pregabalin	36	14
Ventolin Hfa	Albuterol Sulfate	35	18
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	34	32
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	34	suppressed
Clonidine	Clonidine	33	suppressed
Fluconazole	Fluconazole	33	26
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	33	12
Triamcinolone Acetonide	Triamcinolone Acetonide	33	24
Valacyclovir	Valacyclovir Hcl	32	14
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	31	suppressed
Azithromycin	Azithromycin	31	27
Bumetanide	Bumetanide	29	suppressed
Mupirocin	Mupirocin	29	27
Lidocaine	Lidocaine	28	13
Methocarbamol	Methocarbamol	28	14
Rexulti	Brexpiprazole	28	suppressed
Glipizide	Glipizide	26	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	26	suppressed
Baclofen	Baclofen	25	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	25	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	25	suppressed
Linzess	Linaclotide	24	suppressed
Spironolactone-Hctz	Spironolact/Hydrochlorothiazid	24	suppressed
Farxiga	Dapagliflozin Propanediol	23	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	23	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	22	suppressed
Sucralfate	Sucralfate	22	17
Jardiance	Empagliflozin	21	suppressed
Temazepam	Temazepam	21	suppressed
Enalapril Maleate	Enalapril Maleate	20	suppressed
Mirtazapine	Mirtazapine	20	suppressed
Nifedipine Er	Nifedipine	20	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	20	suppressed
Ondansetron Hcl	Ondansetron Hcl	20	suppressed
Azelastine Hcl	Azelastine Hcl	19	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	19	17
Irbesartan	Irbesartan	19	suppressed
Lovastatin	Lovastatin	19	suppressed
Nitrofurantoin	Nitrofurantoin Macrocrystal	19	suppressed
Amlodipine-Valsartan	Amlodipine Besylate/Valsartan	18	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	18	suppressed
Propranolol Hcl Er	Propranolol Hcl	18	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	18	suppressed
Benazepril Hcl	Benazepril Hcl	17	suppressed
Chlorthalidone	Chlorthalidone	17	suppressed
Nystatin	Nystatin	17	suppressed
Tramadol Hcl-Acetaminophen	Tramadol Hcl/Acetaminophen	17	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	16	suppressed
Testosterone Cypionate	Testosterone Cypionate	16	suppressed
Atenolol	Atenolol	15	suppressed
Clobetasol Propionate	Clobetasol Propionate	15	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	15	11
Desvenlafaxine Succinate Er	Desvenlafaxine Succinate	15	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	15	suppressed
Naltrexone Hcl	Naltrexone Hcl	15	suppressed
Prazosin Hcl	Prazosin Hcl	15	suppressed
Valsartan	Valsartan	15	suppressed
Aripiprazole	Aripiprazole	14	suppressed
Breo Ellipta	Fluticasone/Vilanterol	14	suppressed
Eszopiclone	Eszopiclone	14	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	14	suppressed
Paroxetine Hcl	Paroxetine Hcl	14	suppressed
Ramipril	Ramipril	14	suppressed
Candesartan Cilexetil	Candesartan Cilexetil	13	suppressed
Cefdinir	Cefdinir	13	13
Celecoxib	Celecoxib	13	suppressed
Constulose	Lactulose	13	suppressed
Fenofibrate	Fenofibrate	13	suppressed
Hydralazine Hcl	Hydralazine Hcl	13	suppressed
Januvia	Sitagliptin Phosphate	13	suppressed
Meclizine Hcl	Meclizine Hcl	13	11
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	13	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	13	suppressed
Clorazepate Dipotassium	Clorazepate Dipotassium	12	suppressed
Dexmethylphenidate Hcl Er	Dexmethylphenidate Hcl	12	suppressed
Digoxin	Digoxin	12	suppressed
Terbinafine Hcl	Terbinafine Hcl	12	suppressed
Klor-Con M20	Potassium Chloride	11	suppressed
Lamotrigine	Lamotrigine	11	suppressed
Myrbetriq	Mirabegron	11	suppressed
Primidone	Primidone	11	suppressed
Rybelsus	Semaglutide	11	suppressed
Verapamil Er	Verapamil Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error